全文获取类型
收费全文 | 2363篇 |
免费 | 151篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 167篇 |
妇产科学 | 24篇 |
基础医学 | 274篇 |
口腔科学 | 60篇 |
临床医学 | 254篇 |
内科学 | 526篇 |
皮肤病学 | 29篇 |
神经病学 | 57篇 |
特种医学 | 494篇 |
外科学 | 231篇 |
综合类 | 31篇 |
预防医学 | 140篇 |
眼科学 | 18篇 |
药学 | 100篇 |
中国医学 | 3篇 |
肿瘤学 | 123篇 |
出版年
2023年 | 9篇 |
2022年 | 19篇 |
2021年 | 54篇 |
2020年 | 41篇 |
2019年 | 53篇 |
2018年 | 66篇 |
2017年 | 32篇 |
2016年 | 45篇 |
2015年 | 48篇 |
2014年 | 54篇 |
2013年 | 94篇 |
2012年 | 75篇 |
2011年 | 61篇 |
2010年 | 105篇 |
2009年 | 74篇 |
2008年 | 61篇 |
2007年 | 53篇 |
2006年 | 53篇 |
2005年 | 55篇 |
2004年 | 45篇 |
2003年 | 30篇 |
2002年 | 39篇 |
2001年 | 18篇 |
2000年 | 29篇 |
1999年 | 29篇 |
1998年 | 138篇 |
1997年 | 119篇 |
1996年 | 128篇 |
1995年 | 93篇 |
1994年 | 77篇 |
1993年 | 84篇 |
1992年 | 25篇 |
1991年 | 30篇 |
1990年 | 23篇 |
1989年 | 66篇 |
1988年 | 54篇 |
1987年 | 65篇 |
1986年 | 54篇 |
1985年 | 54篇 |
1984年 | 26篇 |
1983年 | 37篇 |
1982年 | 37篇 |
1981年 | 24篇 |
1980年 | 38篇 |
1979年 | 17篇 |
1978年 | 17篇 |
1977年 | 18篇 |
1976年 | 27篇 |
1975年 | 24篇 |
1967年 | 3篇 |
排序方式: 共有2539条查询结果,搜索用时 15 毫秒
1.
2.
JA HYEON KU CHEOL KWAK SEUNG-JUNE OH EUNSIK LEE SANG EUN LEE JAE-SEUNG PAICK 《International journal of urology》2004,11(7):489-493
BACKGROUND: Our aims in the present study were to estimate the influences of pain and urinary symptoms on quality of life, and to determine which of these two variables has the most predictive power with respect to quality of life in young men with chronic prostatitis-like symptoms. METHODS: Chronic prostatitis-like symptoms were measured by the National Institutes of Health-Chronic Prostatitis Symptom Index. Of the 28,841 men aged 20 years who lived in the study community, 18,495 men (a response rate 64.1%) agreed to participate in the study. A total of 1057 men who complained of symptoms indicative of chronic prostatitis were included in the study. The influences of pain and urinary symptoms on quality of life were determined using logistic regression analysis. The receiver operating characteristic (ROC) curve was used to estimate the predictive ability of each of these variables with respect to quality of life. RESULTS: Results from multivariate analysis showed that both pain and urinary symptoms were associated with an increased likelihood of impaired quality of life, although pain contributed more to a reduced quality of life than urinary symptoms. Relative to men who experienced mild pain, men who experienced moderate pain had a 3.9-fold risk of poor quality of life (odds ratio [OR], 3.87; 95% confidence interval [CI], 2.86-5.23; P < 0.001) and those who experienced severe pain had a 15.7-fold risk of reduced quality of life (OR, 15.68; 95% CI, 6.59-37.35; P < 0.001). Moderate urinary symptoms were associated with a 1.4-fold risk of bother (OR, 1.41; 95% CI, 1.01-1.99; P < 0.001) and severe urinary symptoms were associated with 2.4-fold risk (OR, 2.39; 95% CI, 1.37-4.12; P < 0.001), relative to mild urinary symptoms. Comparison of the effects of pain and urinary symptoms showed that pain severity had the most predictive power for bother, quality of life, and quality-of-life impact. The areas under the ROC curves for bother, quality of life, and quality-of-life impact were 71.3%, 69.3% and 72.5%, respectively. CONCLUSION: Urinary symptoms and pain might be associated with an increased likelihood of impaired quality of life in young men with chronic prostatitis-like symptoms. In addition, our findings suggest that pain severity is the most influential variable for determining quality of life in this population. 相似文献
3.
4.
5.
6.
7.
8.
Shelby D Reed Peter W Dillingham Andrew H Briggs David L Veenstra Sean D Sullivan 《Medical decision making》2003,23(3):252-264
Pharmacy and therapeutics committees commonly cite a lack of generalizability as a reason for not incorporating cost-effectiveness information into decision making. To address this concern, many committees undertake site-specific economic evaluations, which are often limited by small sample sizes and nonrandomized designs. We show how 2 complementary approaches were used to minimize these limitations in an economic evaluation of abciximab at 1 institution. Using a propensity score methodology, we selected patients who did not receive abciximab for the comparison cohort. Then, we adopted a Bayesian, hierarchical, random-effects model to integrate site-specific and clinical trial data. We applied the posterior distributions of effectiveness with local cost data in a traditional decision-analytic model. In 74% of the simulations, abciximab was cost-effective at 1 institution at the $50,000 per life year saved threshold, assuming a 50:50 split of patients undergoing coronary stenting and angioplasty. Among patients undergoing coronary stenting, the cost-effectiveness ratio of the addition of abciximab was at or below the $50,000 per life year saved threshold in 66.0% of the simulations. 相似文献
9.
10.
Effect of ibuprofen and interleukin 2 on transfusion-induced suppression of cell-mediated immunity 总被引:1,自引:0,他引:1
Transfusion-induced immunosuppression has been associated with excessive production of prostaglandin E and decreased interleukin 2 (IL-2) production. In the present study, allogeneic blood-transfused mice were tested for cell-mediated immunity with the use of a delayed-type hypersensitivity assay. In vivo administration of a cyclo-oxygenase inhibitor, ibuprofen, and murine recombinant IL-2 was initiated on day 0 and continued daily throughout the delayed-type hypersensitivity assay. The results indicate that prostaglandin E may play a primary role in allogeneic blood transfusion-induced suppression, as manifest by normal responses in ibuprofen-treated mice. Supplementation of transfused mice with recombinant IL-2 also preserved immune response, indicating inadequate IL-2 production after transfusion, while receptor expression appears to remain intact. 相似文献